Conflict of interest
Noboru Nakaigawa: Honoraria from Biopharma, BMS, Merck, MSD, Ono Pharmaceutical, Pfizer and Takeda. Yoshihiko Tomita: Research grants from Astellas, Ono Pharmaceutical and Takeda; and honoraria from Astellas, BMS, Ono Pharmaceutical and Pfizer. Satoshi Tamada: Honoraria from Merck Biopharma, MSD, Pfizer and Takeda. Katsunori Tatsugami: Honoraria from BMS, Merck Biopharma, MSD, Ono Pharmaceutical, Pfizer and Takeda. Takahiro Osawa: Honoraria from Takeda. Mototsugu Oya: Honoraria from Bayer, Bristol-Myers Squibb, Eisai, Merck, MSD, Novartis, Ono, Pfizer, and Takeda; scholarship donations from Bayer, Ono Pharmaceutical and Takeda. Hiroomi Kanayama: No conflict of interest to disclose. Yuji Miura: Research funding from MSD, Ono Pharmaceutical; and honoraria from Bristol-Myers Squibb, Eisai, and Takeda. Naoto Sassa: No conflict of interest to disclose. Kazuo Nishimura: Honoraria from Merck Biopharma. Masahiro Nozawa: Honoraria from Takeda. Naoya Masumori: Research funding from Astellas, Bristol Myers Squibb and MSD; honoraria from Astellas, Astrazeneca, Bayer, Janssen, Kissei and Takeda. Yasuhide Miyoshi: No conflict of interest to disclose. Shingo Kuroda: An employee and stock owner of Takeda Pharmaceutical Company Limited. Akiko Kimura: An employee of Takeda Pharmaceutical Company Limited.